A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome

Europace

Volumn 12, Issue 3, 2010, Pages 410-416

  Nakano, Yukiko ^a   Shimizu, Wataru ^b   Ogi, Hiroshi ^a   Suenari, Kazuyoshi ^a   Oda, Noboru ^a   Makita, Yuko ^a   Kajihara, Kenta ^a   Hirai, Yukoh ^a   Sairaku, Akinori ^a   Tokuyama, Takehito ^a   Tonouchi, Yukiji ^a   Ueda, Shigeyuki ^a   Sueda, Taijiro ^a   Chayama, Kazuaki ^a   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atrial fibrillation; Brugada syndrome; Risk stratification; SCN5A; Sudden death; Ventricular fibrillation

Indexed keywords

ADULT; ARTICLE; BRUGADA SYNDROME; DEFIBRILLATION; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADULT; BRUGADA SYNDROME; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE PROTEINS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHANNELS; VENTRICULAR FIBRILLATION;

EID: 77749320147     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup446     Document Type: Article

References (21)

1. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Longterm follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
2. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-7.
3. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-6.
4. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257- 63.
5. Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 2008;72:1926-36.
6. Atarashi H, Ogawa S. Idiopathic ventricular fibrillation investigators. New ECG criteria for high-risk Brugada syndrome. Circ J 2003;67:8-10.
7. Morita H, Takenaka-Morita S, Fukushima-Kusano K, Kobayashi M, Nagase S, Kakishita M et al. Risk stratification for asymptomatic patients with Brugada syndrome. Circ J 2003;67:312-6.
8. Babai Bigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic eventsinpatients with Brugada syndrome. Heart Rhythm 2007;4:1009-12.
9. Takagi M, Yokoyama Y, Aonuma K, Aihara N, Hiraoka M, Japan idiopathic ventricular fibrillation study (J-IVFS) investigators. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with Brugada syndrome: multicenter study in Japan. J Cardiovasc Electrophysiol 2007;18:1244-51.
10. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006;47:1828-34.
11. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P et al. Study group on the molecular basis of arrhythmias of the European Society of Cardiology: proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106:2514-9.
12. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70.
13. Shimizu W, Aiba T, Kamakura S. Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2005;2:408-14.
14. Bezzina CR, Shimizu W, Yang P, Koopmann TT, Tanck MW, Miyamoto Y et al. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 2006;113:338-44.
15. Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M et al. for the Brugada syndrome investigators in Japan Long-term prognosis of probands with Brugada-pattern ST elevation on V1-V3 leads Circ Arrhythmia Electrophysiol 2009;2:495-503.
16. Eckardt L, Kirchhof P, Loh P, Schulze-Bahr E, Johna R, Wichter T et al. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol 2001;12:680-5.
17. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006;29:1130-59.
18. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008;51:1169-75.
19. Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-92.
20. Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde AA et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J 2007;17:2126-33.
21. Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000;11:396-404.